BRKR – Bruker Corporation
BRKR — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
13.17
Margin Of Safety %
-14
Put/Call OI Ratio
0.27
EPS Next Q Diff
0.06
EPS Last/This Y
2.27
EPS This/Next Y
0.31
Price
53.4
Target Price
58.75
Analyst Recom
2
Performance Q
22.14
Upside
-109.9%
Beta
1.24
Ticker: BRKR
20 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-13 | BRKR | 58.93 | 0.16 | 0.82 | 17820 |
| 2026-07-14 | BRKR | 59.85 | 0.17 | 1.00 | 17938 |
| 2026-07-15 | BRKR | 58.67 | 0.17 | 0.20 | 17987 |
| 2026-07-16 | BRKR | 59.28 | 0.17 | 0.36 | 18005 |
| 2026-07-17 | BRKR | 64.95 | 0.17 | 0.03 | 18018 |
| 2026-07-20 | BRKR | 56.16 | 0.15 | 0.10 | 12262 |
| 2026-07-21 | BRKR | 60.4 | 0.14 | 0.08 | 12576 |
| 2026-07-22 | BRKR | 59.71 | 0.14 | 0.28 | 12820 |
| 2026-07-23 | BRKR | 62.16 | 0.14 | 0.10 | 12932 |
| 2026-07-24 | BRKR | 60.44 | 0.14 | 7.29 | 14054 |
| 2026-07-27 | BRKR | 60.02 | 0.15 | 6.25 | 14183 |
| 2026-07-28 | BRKR | 62.9 | 0.15 | 0.20 | 14221 |
| 2026-07-29 | BRKR | 61.72 | 0.17 | 1.30 | 14045 |
| 2026-07-30 | BRKR | 64.32 | 0.15 | 0.07 | 13887 |
| 2026-07-31 | BRKR | 62.82 | 0.15 | 0.06 | 14024 |
| 2026-08-03 | BRKR | 64.36 | 0.16 | 0.52 | 13603 |
| 2026-08-04 | BRKR | 50.29 | 0.23 | 0.30 | 17570 |
| 2026-08-05 | BRKR | 52.47 | 0.27 | 0.78 | 17435 |
| 2026-08-06 | BRKR | 51.28 | 0.28 | 0.09 | 17726 |
| 2026-08-07 | BRKR | 53.45 | 0.27 | 0.01 | 17882 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-13 | BRKR | 58.92 | 19.6 | - | 2.12 |
| 2026-07-14 | BRKR | 59.86 | 19.6 | - | 2.12 |
| 2026-07-15 | BRKR | 58.67 | 20.1 | - | 2.12 |
| 2026-07-16 | BRKR | 59.24 | 20.1 | - | 2.12 |
| 2026-07-17 | BRKR | 58.22 | 20.1 | - | 2.12 |
| 2026-07-20 | BRKR | 56.19 | 20.1 | - | 2.12 |
| 2026-07-21 | BRKR | 60.42 | 20.1 | - | 2.12 |
| 2026-07-22 | BRKR | 59.71 | 20.1 | - | 2.12 |
| 2026-07-23 | BRKR | 62.15 | 20.1 | - | 2.12 |
| 2026-07-24 | BRKR | 60.44 | 20.1 | - | 2.12 |
| 2026-07-27 | BRKR | 60.04 | 20.1 | - | 2.12 |
| 2026-07-28 | BRKR | 62.92 | 20.1 | - | 2.12 |
| 2026-07-29 | BRKR | 61.72 | 20.1 | - | 2.12 |
| 2026-07-30 | BRKR | 64.32 | 20.1 | - | 2.12 |
| 2026-07-31 | BRKR | 62.82 | 20.1 | - | 2.12 |
| 2026-08-03 | BRKR | 64.34 | 20.1 | - | 2.12 |
| 2026-08-04 | BRKR | 64.34 | 20.1 | - | 2.12 |
| 2026-08-05 | BRKR | 52.48 | 20.1 | - | 2.12 |
| 2026-08-06 | BRKR | 51.24 | 20.1 | - | 2.12 |
| 2026-08-07 | BRKR | 53.40 | 20.1 | - | 2.12 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-13 | BRKR | -0.05 | -0.11 | 11.35 |
| 2026-07-14 | BRKR | -0.03 | -0.11 | 11.35 |
| 2026-07-15 | BRKR | -0.03 | -0.11 | 11.35 |
| 2026-07-16 | BRKR | -0.03 | -0.11 | 11.35 |
| 2026-07-17 | BRKR | -0.03 | -0.11 | 11.35 |
| 2026-07-20 | BRKR | -0.03 | -0.23 | 11.35 |
| 2026-07-21 | BRKR | -0.03 | -0.23 | 11.35 |
| 2026-07-22 | BRKR | -0.03 | -0.23 | 11.35 |
| 2026-07-23 | BRKR | -0.03 | -0.23 | 11.35 |
| 2026-07-24 | BRKR | -0.03 | -0.23 | 11.35 |
| 2026-07-27 | BRKR | -0.03 | -0.23 | 13.17 |
| 2026-07-28 | BRKR | -0.03 | -0.23 | 13.17 |
| 2026-07-29 | BRKR | -0.03 | -0.23 | 13.17 |
| 2026-07-30 | BRKR | -0.03 | -0.23 | 13.17 |
| 2026-07-31 | BRKR | -0.03 | -0.23 | 13.17 |
| 2026-08-03 | BRKR | -0.03 | -0.65 | 13.17 |
| 2026-08-04 | BRKR | -0.03 | -0.65 | 13.17 |
| 2026-08-05 | BRKR | -0.03 | -0.65 | 13.17 |
| 2026-08-06 | BRKR | -0.03 | -0.65 | 13.17 |
| 2026-08-07 | BRKR | -0.03 | -0.65 | 13.17 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
20 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
0.49
Avg. EPS Est. Current Quarter
0.38
Avg. EPS Est. Next Quarter
0.55
Insider Transactions
-0.03
Institutional Transactions
-0.65
Beta
1.24
Average Sales Estimate Current Quarter
853
Average Sales Estimate Next Quarter
897
Fair Value
45.68
Quality Score
51
Growth Score
59
Sentiment Score
8
Actual DrawDown %
43.7
Max Drawdown 5-Year %
-68.7
Target Price
58.75
P/E
Forward P/E
22.15
PEG
1.44
P/S
2.35
P/B
3.32
P/Free Cash Flow
158.63
EPS
-0.24
Average EPS Est. Cur. Y
2.12
EPS Next Y. (Est.)
2.43
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-1.05
Relative Volume
0.79
Return on Equity vs Sector %
-31.8
Return on Equity vs Industry %
-16
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
◆
BRKR
Healthcare
$53.41
📉
N/A
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
8/20
Pullback
21/25
Volume
6/15
Valuation
11/20
TP/AR
3/10
Options
8/10
RSI
42.8
Range 1M
25.5%
Sup Dist
5%
🚀
N/A
Momentum Growth
Ride accelerating trends
WEAK
Momentum
10/25
Growth
15/30
Estimates
4/20
Inst/Vol
4/15
Options
8/10
EPS Yr
16%
EPS NY
13.6%
52W%
66.2%
💎
N/A
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-2.3% upside
Quality
5/30
Valuation
3/30
Growth
12/25
Stability
6/10
LT Trend
3/5
Upside
-2.3%
Quality
51
MoS
-14%
Click a card to see score breakdown
Full Analysis →
BRKR — P/E HistoricalMedical Devices
Sector: Healthcare
Industry: Medical Devices
Employees: 11085
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
BRKR
Latest News
—
Caricamento notizie per BRKR…
stock quote shares BRKR – Bruker Corporation Stock Price stock today
news today BRKR – Bruker Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch BRKR – Bruker Corporation yahoo finance google finance
stock history BRKR – Bruker Corporation invest stock market
stock prices BRKR premarket after hours
ticker BRKR fair value insiders trading